Fluctuations in exhaled hydrogen gas due to oral administration of fructooligosaccharides
Phase 1
Recruiting
- Conditions
- threatened preterm birthPreterm Birth
- Registration Number
- JPRN-jRCTs021220023
- Lead Sponsor
- Miura Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
1) Maternal age: 18 years old and over, under 50 years old
2) 50 healthy women without complications
3) 50 pregnant women who are planning to deliver at our department.
Exclusion Criteria
If not gain consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Make healthy women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree <br>2) Make pregnant women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree
- Secondary Outcome Measures
Name Time Method Evaluation of side effects and other safety caused by fructooligosaccharide